Ro Review

Ro at a glance: the widest GLP-1 menu in telehealth

Ro is one of the largest direct-to-patient healthcare companies in the country, and for weight management it carries something almost no competitor matches: nearly the full GLP-1 shelf under one login. You can get compounded semaglutide, brand-name Wegovy, brand-name Zepbound (a tirzepatide product), and — as of April 9, 2026 — Eli Lilly's new oral GLP-1 pill, Foundayo (orforglipron), which Ro began offering on the day it launched. If your priority is options rather than a single rock-bottom price, Ro is built for exactly that.

The trade-off is that Ro's model is membership-first, not medication-first. The platform sells you access to care and a licensed provider; the drug is billed separately. That makes Ro flexible, but it also means the number you see advertised is rarely the number you actually pay each month.

How Ro's pricing actually works

This is the part worth slowing down on. Ro confirmed at launch that Foundayo starts at a cash-pay price of roughly one hundred fifty dollars a month for the lowest dose — but the same announcement spells out that additional membership fees apply on top of that. So the headline drug price is not your all-in cost. You're paying two things: the medication, and a recurring Ro Body membership that covers the provider visits, messaging, coaching, and labs.

• The medication and the membership are billed as two separate charges, so your true monthly outlay is higher than the advertised drug price.
• Pricing for Foundayo doses above the lowest one isn't published — you only see it during intake.
• For context, the category median monthly price across providers we track sits around $170, and Ro's lowest-dose drug price undercuts that, but the membership narrows the gap.

None of this is hidden, exactly — Ro states plainly that the cost of GLP-1 medication is not included in the membership. But it does put the burden on you to add the two pieces together before you decide whether Ro is cheaper than a flat-fee competitor.

The medications, and how they're dispensed

Where Ro genuinely stands apart is breadth. Most telehealth providers pick a lane — compounded-only, or brand-only. Ro spans both. You can start on lower-cost compounded semaglutide, step up to brand-name Wegovy or Zepbound if you want an FDA-approved branded injection, or skip needles entirely with the Foundayo pill. Prescriptions are filled through Roman Health Pharmacy LLC or one of the partner pharmacies in what Ro calls its Pharmacy Network, with nationwide delivery the company says reaches even most primary-care deserts.

A practical upside of carrying everything: a licensed provider can actually help you choose between the options based on cost, your insurance, and your goals, rather than defaulting you to the one product they happen to sell. Ro also supports both cash-pay and insurance-eligible paths on the same platform, which is unusual.

What being first to Foundayo really means

Ro's standout differentiator right now is being among the very first platforms to offer oral Foundayo at launch. For people who hate injections or have struggled to keep injectable pens cold and on schedule, a daily GLP-1 pill is a meaningful alternative. Just go in clear-eyed: it's brand-new, the lowest-dose teaser price is the only one published, and the membership stacks on top.

Who should choose Ro — and who should skip it

Ro makes the most sense if you value choice and a real care team: someone who isn't sure whether semaglutide, tirzepatide, or an oral option fits best, and who wants a provider to help sort it out. The included unlimited provider messaging, 1:1 health coaching, and lab testing at Quest locations are legitimate extras that flat drug-only sellers don't bundle.

• Good fit: you want the broadest menu, you're curious about the Foundayo pill, or you want coaching and labs included alongside the prescription.
• Think twice: you want one simple all-in price with nothing to add up, or you're optimizing purely for the cheapest possible monthly cost.

The honest drawbacks are about transparency, not safety. The separate membership-plus-medication billing can make your real cost confusing, dose pricing above the entry tier isn't shown upfront, and Ro doesn't publicly list every state it serves or which pharmacy you'll be matched with until you sign up.

Trust and oversight

On the trust side, Ro is a well-established, large national operator that routes care through licensed providers and fills through its own pharmacy network. We have no FDA warning letters on file for Ro, and its weight-loss claims — including the Foundayo launch details and pricing — are drawn from the company's own April 2026 announcement and its live weight-loss page. As with any compounded option, the usual caveat applies: compounded semaglutide isn't an FDA-approved product the way brand Wegovy or Zepbound is, so weigh that when choosing among Ro's menu. You can see how we weigh formulary breadth, transparency, and oversight in our scoring methodology.

Bottom line

Ro is the closest thing to a one-stop GLP-1 shop: compounded, brand, and now the Foundayo pill, with a provider to help you choose and coaching plus labs built in. It earns its place for breadth and for being early to oral GLP-1. The catch is the math — the advertised drug price isn't the whole bill once membership is added, and higher doses aren't priced publicly. If you want options and guidance, Ro is a strong pick; if you want one flat, predictable number, confirm the all-in total before you commit.

Worth pricing against Telos Rx ($49/month) and bmiMD ($99/month) before you commit — both sit close to Ro on cost and formulation.